Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...

Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...